AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2024
Aug 20, 2024
32566_dirs_2024-08-20_8721a14b-8d70-4e78-bca1-07a1e47c4178.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2024-08-19
Reporting Person: Kumar Rashmi (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-19 | Common Stock | S | 7500 | $28.01 | Disposed | 77392 | Direct |
Footnotes
F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2